NO20080860L - Substituert propanamidderivat og farmasoytisk preparat som inneholder dette - Google Patents
Substituert propanamidderivat og farmasoytisk preparat som inneholder detteInfo
- Publication number
- NO20080860L NO20080860L NO20080860A NO20080860A NO20080860L NO 20080860 L NO20080860 L NO 20080860L NO 20080860 A NO20080860 A NO 20080860A NO 20080860 A NO20080860 A NO 20080860A NO 20080860 L NO20080860 L NO 20080860L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- composition containing
- substituted
- propanamide derivative
- substituted propanamide
- Prior art date
Links
- 239000008194 pharmaceutical composition Chemical class 0.000 title abstract 2
- QLNJFJADRCOGBJ-LBPDFUHNSA-N propanamide Chemical class CC[13C](N)=O QLNJFJADRCOGBJ-LBPDFUHNSA-N 0.000 title abstract 2
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000004097 bone metabolism Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/31—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005208036 | 2005-07-19 | ||
| PCT/JP2006/314144 WO2007010885A1 (fr) | 2005-07-19 | 2006-07-18 | Dérivé de propanamide substitué et composition pharmaceutique contenant celui-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080860L true NO20080860L (no) | 2008-04-18 |
Family
ID=37668765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080860A NO20080860L (no) | 2005-07-19 | 2008-02-18 | Substituert propanamidderivat og farmasoytisk preparat som inneholder dette |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8344029B2 (fr) |
| EP (1) | EP1908466B1 (fr) |
| JP (1) | JP5311822B2 (fr) |
| KR (1) | KR20080027850A (fr) |
| CN (1) | CN101267813A (fr) |
| AU (1) | AU2006270914B2 (fr) |
| BR (1) | BRPI0613423A2 (fr) |
| CA (1) | CA2615991C (fr) |
| IL (1) | IL188839A (fr) |
| MX (1) | MX2008000971A (fr) |
| NO (1) | NO20080860L (fr) |
| NZ (1) | NZ565141A (fr) |
| RU (1) | RU2394560C2 (fr) |
| TW (1) | TWI371272B (fr) |
| WO (1) | WO2007010885A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI396543B (zh) * | 2005-05-12 | 2013-05-21 | Sankyo Co | 取代丙烯醯胺衍生物及含有它之醫藥組成物 |
| JP2011026201A (ja) * | 2007-10-17 | 2011-02-10 | Mitsubishi Tanabe Pharma Corp | 光学活性ピロリル−コハク酸イミド誘導体の立体選択的な製造方法 |
| RU2623034C1 (ru) * | 2016-07-28 | 2017-06-21 | Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук | Противоопухолевое средство |
| WO2018213150A1 (fr) | 2017-05-15 | 2018-11-22 | Mitobridge, Inc. | Inhibiteurs de usp30 |
| CN117050045B (zh) * | 2023-10-10 | 2023-12-22 | 长沙创新药物工业技术研究院有限公司 | 一种s构型羟丙基四氢吡喃三醇的合成方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5521737B2 (fr) | 1972-12-23 | 1980-06-12 | ||
| IT1062206B (it) * | 1974-02-01 | 1983-09-20 | Rotta Research Lab S P A A S | Derivati della tirosina attivi sulla muscolatura liscia |
| US4621092A (en) | 1982-07-22 | 1986-11-04 | E. R. Squibb & Sons, Inc. | Substituted proline compounds, composition and method of use |
| AU598750B2 (en) * | 1985-09-27 | 1990-07-05 | Mitsubishi Chemical Corporation | Phenylalanine derivative and proteinase inhibitor |
| WO1997019908A1 (fr) * | 1995-11-29 | 1997-06-05 | Nihon Nohyaku Co., Ltd. | Derives de phenylalanine, substances optiquement actives, leurs sels ou composes de coordination, et leur utilisation en tant que fongicides |
| AU5692398A (en) | 1996-12-09 | 1998-07-03 | Proscript, Inc. | Substituted 5-amino-1,3,4-thiadiazole-2-thiones |
| EP0977989A1 (fr) | 1997-02-04 | 2000-02-09 | Trega Biosciences, Inc. | Derives de la quinoline substituee en 4- et bibliotheques combinatoires les contenant |
| CN1213036C (zh) * | 1997-08-22 | 2005-08-03 | 科研制药株式会社 | 新的酰胺类衍生物 |
| HUP0004400A3 (en) * | 1997-11-05 | 2002-10-28 | Novartis Ag | Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use |
| CA2328396C (fr) * | 1998-04-20 | 2009-02-10 | Basf Aktiengesellschaft | Inhibiteurs de protease de cysteine |
| AU4329399A (en) | 1998-07-30 | 2000-02-21 | Warner-Lambert Company | Tyrosine-derived compounds as calcium channel antagonists |
| GB9828442D0 (en) * | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| YU58601A (sh) * | 1999-02-18 | 2004-05-12 | F.Hoffmann-La Roche Ag. | Derivati fenilalaninola |
| WO2000059874A1 (fr) * | 1999-04-02 | 2000-10-12 | Du Pont Pharmaceuticals Company | Nouveaux derives d'amides faisant office d'inhibiteurs de metalloproteases matricielles, de tnf-alpha, et de l'aggrecanase |
| DE10204951A1 (de) | 2002-02-06 | 2003-08-14 | Basf Ag | Phenylalaninderivate als Herbizide |
| WO2003075836A2 (fr) | 2002-03-05 | 2003-09-18 | Merck Frosst Canada & Co. | Inhibiteurs de cathepsine cysteine protease |
| WO2004026851A1 (fr) | 2002-09-20 | 2004-04-01 | Axys Pharmaceuticals, Inc. | Derives de 4-hydroxyphenyl-3-3,5-disubstitue-propionamide en tant qu'inhibiteurs de cathepsine b |
| AU2003298740A1 (en) | 2002-12-05 | 2004-06-30 | Axys Pharmaceuticals, Inc. | Cyanomethyl derivatives as cysteine protease inhibitors |
| US20040167183A1 (en) | 2003-02-20 | 2004-08-26 | The Procter & Gamble Company | Phenethylamino sulfamic acids |
| US7109243B2 (en) | 2003-03-24 | 2006-09-19 | Irm Llc | Inhibitors of cathepsin S |
| CA2528231A1 (fr) * | 2003-06-13 | 2004-12-23 | Laboratorios S.A.L.V.A.T., S.A. | Nouveaux benzamides en tant que modulateurs de ppar.gamma. |
| GB0329584D0 (en) * | 2003-12-20 | 2004-01-28 | Tanabe Seiyaku Co | Novel compounds |
| WO2005097103A2 (fr) * | 2004-04-01 | 2005-10-20 | Axys Pharmaceuticals, Inc. | Traitement du diabete et du syndrome metabolique au moyen d'inhibiteurs de la cathepsine b |
| US7618981B2 (en) * | 2004-05-06 | 2009-11-17 | Cytokinetics, Inc. | Imidazopyridinyl-benzamide anti-cancer agents |
-
2006
- 2006-07-18 JP JP2007526005A patent/JP5311822B2/ja not_active Expired - Fee Related
- 2006-07-18 CA CA2615991A patent/CA2615991C/fr not_active Expired - Fee Related
- 2006-07-18 US US11/996,268 patent/US8344029B2/en not_active Expired - Fee Related
- 2006-07-18 CN CNA2006800343749A patent/CN101267813A/zh active Pending
- 2006-07-18 TW TW095126137A patent/TWI371272B/zh not_active IP Right Cessation
- 2006-07-18 WO PCT/JP2006/314144 patent/WO2007010885A1/fr not_active Ceased
- 2006-07-18 RU RU2008102132/04A patent/RU2394560C2/ru not_active IP Right Cessation
- 2006-07-18 BR BRPI0613423-8A patent/BRPI0613423A2/pt not_active IP Right Cessation
- 2006-07-18 AU AU2006270914A patent/AU2006270914B2/en not_active Ceased
- 2006-07-18 NZ NZ565141A patent/NZ565141A/en not_active IP Right Cessation
- 2006-07-18 EP EP06781166.1A patent/EP1908466B1/fr not_active Not-in-force
- 2006-07-18 MX MX2008000971A patent/MX2008000971A/es active IP Right Grant
- 2006-07-18 KR KR1020087001397A patent/KR20080027850A/ko not_active Abandoned
-
2008
- 2008-01-17 IL IL188839A patent/IL188839A/en not_active IP Right Cessation
- 2008-02-18 NO NO20080860A patent/NO20080860L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200740428A (en) | 2007-11-01 |
| JPWO2007010885A1 (ja) | 2009-01-29 |
| RU2008102132A (ru) | 2009-07-27 |
| AU2006270914A1 (en) | 2007-01-25 |
| MX2008000971A (es) | 2008-03-27 |
| CA2615991C (fr) | 2011-02-08 |
| EP1908466A1 (fr) | 2008-04-09 |
| KR20080027850A (ko) | 2008-03-28 |
| BRPI0613423A2 (pt) | 2012-12-11 |
| EP1908466B1 (fr) | 2014-02-19 |
| NZ565141A (en) | 2010-12-24 |
| IL188839A0 (en) | 2008-04-13 |
| US8344029B2 (en) | 2013-01-01 |
| AU2006270914B2 (en) | 2011-01-20 |
| CA2615991A1 (fr) | 2007-01-25 |
| RU2394560C2 (ru) | 2010-07-20 |
| CN101267813A (zh) | 2008-09-17 |
| EP1908466A4 (fr) | 2012-05-30 |
| US20090292024A1 (en) | 2009-11-26 |
| WO2007010885A1 (fr) | 2007-01-25 |
| TWI371272B (en) | 2012-09-01 |
| IL188839A (en) | 2012-10-31 |
| JP5311822B2 (ja) | 2013-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
| NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
| ATE540932T1 (de) | Hydantoin-derivate als antibakterielle wirkstoffe | |
| NO20076059L (no) | 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer | |
| NO20074012L (no) | 1-tio-D-glucitolderivater | |
| BRPI0608436A2 (pt) | derivados de n-(n-sulfonilaminometil) ciclopropanocarboxamida utilizáveis para o tratamento de dor | |
| EA201270546A1 (ru) | ЗАМЕЩЕННЫЕ ПИПЕРИДИНЫ, КОТОРЫЕ ПОВЫШАЮТ АКТИВНОСТЬ p53, И ИХ ПРИМЕНЕНИЕ | |
| NO20091620L (no) | Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser | |
| NO20080914L (no) | Mellomprodukt for syntetisering av farmasoytisk middel og fremgangsmate for fremstilling av dette | |
| NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
| WO2007082808A3 (fr) | Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1 | |
| EA200900066A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил) -d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
| BRPI0513433A (pt) | derivados de hidantoìna para o tratamento de distúrbios inflamatórios | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
| NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
| NO20092535L (no) | Fumaratsalt av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol | |
| NO20082496L (no) | Pyrazinderivater | |
| NO20081844L (no) | Terapeutiske forbindelser | |
| ECSP055595A (es) | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz | |
| ATE442349T1 (de) | Diacylglycerol-acyltransferase-hemmer | |
| BRPI0517567A (pt) | composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo, composição farmacêutica, usos de um composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo e de uma composição farmacêutica, e, processo para preparar um composto | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
| ATE520651T1 (de) | Substituierte phenylmethylbicyclocarbonsäureamidverbindungen | |
| MX2008002061A (es) | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |